Biktarvy, formally known as biktarvy, represents a effective single-tablet treatment for controlling HIV infection. This drug combines three crucial antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by inhibiting the the viral ability to copy within the body, significantly decreasing the viral load. For many